Medifast, Inc.

NYSE:MED

Personal Products & Services

Consumer Cyclical
$12.20 -0.04%

-$0.01 today

Market cap
$136.43M
Beta
0.66
P/E (TTM)
-6.2
EPS (TTM)
-$1.82
52W Low $9.22High $15.46

Volume 0.09M

Average 0.21M

MED EBITDA Margin

EBITDA as a percentage of revenue.

Medifast, Inc.NYSE: MED

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 2.0%

EBITDA Margin was 2.0% in Q1 FY2026, down 1.3 pp from a year earlier. On a trailing-twelve-month basis it was 1.8%, up 0.8 pp year over year. Over 3 fiscal years it narrowed by 11.0 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 1 analysts of 0.9% for the fiscal year ending Dec 2026, down from 1.3% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
2.0%+5.9 pp QoQ
Last fiscal yearDec 2025
1.3%-1.5 pp YoY
LTMMar 2026
1.8%+0.8 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-1.3 pp-11.8 pp-10.6 pp
1 year-1.5 pp-0.3 pp+1.2 pp
3 years-11.0 pp——
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
1.3%
Year-over-year change
-1.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How MED compares with its peers on the latest reported figures

  • MED's LTM Mar 2026 EBITDA Margin of 1.8% is the 6th highest of the 10 companies compared; the peer median is 5.4%.
  • Its year-over-year change of +0.8 pp is the 4th highest of 10, against a peer median of -1.3 pp.
  • Over three fiscal years its change of -11.0 pp compares with a peer median of -1.6 pp.
MED Competitors Peer median
EBITDA Margin for MED and competitors
Company Period LTM level YoY 3-year change
CAASChina Automotive Systems, Inc.LTM Dec 20259.3% -0.8 pp+0.7 pp
KEQUKewaunee Scientific CorporationLTM Jan 20269.3% +2.4 pp+8.9 pp
MBMasterBeef GroupFY20256.7% -18.0 pp-18.3 pp
CURVTorrid Holdings Inc.LTM May 20266.3% -5.1 pp-5.0 pp
BSETBassett Furniture Industries, IncorporatedLTM Feb 20265.4% +5.4 pp-3.8 pp
MEDMedifast, Inc.LTM Mar 20261.8% +0.8 pp-11.0 pp
AKAa.k.a. Brands Holding Corp.LTM Mar 2026-0.0% -1.3 pp+24.8 pp
DIBS1stdibs.Com, Inc.LTM Mar 2026-7.4% +2.6 pp+8.6 pp
CLARClarus CorporationLTM Mar 2026-16.5% -12.7 pp-21.7 pp
AIIORobo.ai Inc.FY2025-16436.0% -15048.5 pp—
Peer median (excluding MED) 5.4%-1.3 pp-1.6 pp

Competitors are the stored peer set for MED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.53B1.6B1.07B602.46M385.79M
Cost of Revenue398.49M458.16M296.2M157.84M110.6M
Gross Profit1.13B1.14B775.85M444.62M275.19M
Gross Margin73.9%71.3%72.4%73.8%71.3%
Research & Development00000
Selling, General & Admin911.36M955.61M649.45M441.75M289.4M
Operating Expenses911.36M955.61M649.45M441.75M289.4M
Depreciation & Amortization6.81M10.98M13.11M12.71M10.5M
EBITDA222.94M195.74M141.9M16.49M4.86M
EBITDA Margin14.6%12.2%13.2%2.7%1.3%
Operating Income216.24M184.81M126.4M2.88M(14.21M)
Operating Margin14.2%11.6%11.8%0.5%-3.7%
Interest Income002.49M4.8M5.52M
Interest Expense231K701K000
Other Income / Expenses(112K)(747K)2.4M909K8.57M
Income Before Tax216.13M184.06M128.8M3.79M(5.64M)
Pre-Tax Margin14.2%11.5%12.0%0.6%-1.5%
Income Tax Expense52.1M40.49M29.38M1.7M13.03M
Net Income164.03M143.57M99.42M2.09M(18.67M)
Net Margin10.7%9.0%9.3%0.3%-4.8%
EPS (Basic)14.0112.829.100.19(1.70)
EPS (Diluted)13.8912.739.100.19(1.70)
Weighted Avg Shares11.71M11.2M10.88M10.93M10.98M
Weighted Avg Shares (Diluted)11.81M11.28M10.92M10.96M10.98M

Medifast, Inc.

NYSE:MED

Intrinsic Alpha fair value

Locked

Current Price

$12.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.